Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
Andrographis paniculata (1 trial)
guanxin shutong (1 trial)
nitroglycerin (transderm-nitro) (1 trial)
anlotinib (2 trials)
sintilimab (1 trial)
personalized neoantigen vaccine (1 trial)
midazolam (versed) (1 trial)
remimazolam (Byfavo) (1 trial)
Acute Disease (Phase 4)
Angina Pectoris (Phase 4)
Angina, Stable (Phase 4)
Bronchitis (Phase 4)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Lung Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Trials (6 total)
Trial APIs (8 total)